SCHEMBL6000287

SCHEMBL6000287

NCCc1ccc(Cl)cc1Oc1cccc2[nH]ccc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RHEB Q15382 11/20 0.66
TRPA1 O75762 1/20 0.50
HTR2A P28223 4/20 0.47
TRPM8 Q7Z2W7 1/20 0.47
CSNK2B P67870 1/20 0.41
CSNK2A1 P68400 1/20 0.41
CHEK1 O14757 1/20 0.39
SCN9A Q15858 1/20 0.39
MPO P05164 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2A6 P11509 1/20 0.38
NFKB1 P19838 1/20 0.38
HTR1D P28221 1/20 0.38
HTR1B P28222 1/20 0.38
HTR2C P28335 1/20 0.38
HTR7 P34969 1/20 0.38
CTSK P43235 1/20 0.38
HTR6 P50406 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000281 0.82 RHEB (0.66) RHEBHTR2ASLC6A4KCNH2
SCHEMBL6000215 0.80 RHEB (0.46) RHEBHTR2ATRPM8CHEK1SLC6A4
SCHEMBL20536492 0.80 RHEB (1.00) RHEBTRPA1SCN9A
SCHEMBL20535781 0.77 RHEB (1.00) RHEBTRPA1SCN9ASLC6A4
SCHEMBL5999729 0.75 AHR (0.49) RHEBHTR2ATRPM8CHEK1SLC6A4
SCHEMBL1499400 0.74 RHEB (0.73) RHEBTRPA1CYP1A2CYP3A4CYP2D6
SCHEMBL5497887 0.74 RHEB (0.51) RHEBHTR2ATRPM8HTR1DHTR6
SCHEMBL16632580 0.73 RHEB (0.63) RHEBTRPA1HTR2CHTR6SLC6A4
SCHEMBL5501246 0.73 TAAR1 (0.50) HTR2ATAAR1SLC6A4KCNH2
SCHEMBL20535840 0.73 RHEB (1.00) RHEBTRPA1HTR2ASLC6A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060058361-A1 Therapeutic diphenyl ether ligands PFIZER INC 2006-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060058361-A1 Therapeutic diphenyl ether ligands HTR2B, HTR2C, HTR3B RHEB 2914/4885TRPA1 172/4885HTR2A 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.